FNBT
DPLO

FineMark National Bank & Trust’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

FineMark National Bank & Trust’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,773
Closed -$22K – 1139
2016
Q4 		$22K Buy
1,773
+1,672
+1,655% +$31.1K ﹤0.01% 810
2016
Q3 		$3K Buy
101
+42
+71% +$1.41K ﹤0.01% 1146
2016
Q2 		$2K Hold
59
– – ﹤0.01% 1240
2016
Q1 		$2K Hold
59
– – ﹤0.01% 1183
2015
Q4 		$2K Buy
+59
New +$1.84K ﹤0.01% 1218

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
HIM
Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FineMark National Bank & Trust's DPLO Position: Q1 2017 in Review

FineMark National Bank & Trust sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2017, closing a stake of 1,773 shares — an estimated $22K sold.

FineMark National Bank & Trust first reported a position in DPLO in Q4 2015 and held it in 5 quarters. The position peaked at $22K in Q4 2016. 155 funds tracked by Wall St. Rank hold DPLO as of Q1 2017.

  • FineMark National Bank & Trust reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2017 after selling out during the quarter.
  • FineMark National Bank & Trust sold 1,773 DIPLOMAT PHARMACY, INC. shares in Q1 2017, an estimated $22K.
  • FineMark National Bank & Trust first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2015 and held it in 5 quarters.
  • FineMark National Bank & Trust's DIPLOMAT PHARMACY, INC. position peaked at $22K in Q4 2016.
  • 155 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2017.

Based on FineMark National Bank & Trust's 13F filing for Q1 2017, filed 12 May 2017.